{"symbol":"BMY","fiscalQuarter":"Q1-2014","reportDate":"2014-04-29","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2014","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Down 2.07%","keyNumbers":[{"metric":"EPS","actual":"$0.46","expected":"N/A","surprise":"+4.31%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported an EPS of $0.46, exceeding expectations by 4.31%. However, the stock dropped by 2.07% in reaction to the earnings report. The lack of revenue data and management commentary may have contributed to investor uncertainty.","metaDescription":"Bristol-Myers Squibb (BMY) Q1 2014 earnings: EPS beat by 4.31%. Stock down 2.07%. Full breakdown."}}